Bing

SEARCH HISTORY

One stock that might be an intriguing choice for investors right now is Zogenix, Inc. (ZGNX). This is because this security in the Medical Drug space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank ...
Yahoo Finance · 5/1/2014
Zogenix (NASDAQ:ZGNX)‘s stock had its “buy” rating reaffirmed by investment analysts at Brean Capital in a note issued to investors on Monday. They currently have a $2.50 price target on the stock. Brean Capital’s price objective would suggest a ...
sleekmoney.com · 6/15/2015
Zogenix Inc. (ZGNX) experienced unusually high volume on Jun. 25, as the stock gained 2.45% to a closing price of $1.67. The stock saw 3.83 million shares trade hands over the course of the day on 6,469 trades. Given that the stock’s average daily …
Equities · 6/25/2015
More from Bing News
Stocks of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $0.52 in last session with the total traded volume of 1.65 Million. The Financial Institutional ownership of the firm was 27.10% while by insiders was 0.70%. Zogenix, Inc. (NASDAQ:ZGNX ...
emarketsdaily.com · 1/13/2015
Zogenix Inc (NASDAQ: ZGNX), Quepasa Corporation (NYSE: QPSA), and Unilife Corp (NASDAQ: UNIS) are some such stocks which have come off in the recent days but are otherwise recommended highly by analysts and generally have more than one …
Smallcap Network · ByBrian Prescott · 3/1/2012
The reverse stock split will not affect any shareholder's ownership percentage of Zogenix's common shares. The common shares will trade under a new CUSIP number, 98978L 204, effective July 1, 2015. Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical …
4 Traders · 6/18/2015
Zogenix Inc. (NASDAQ: ZGNX) is down 5 percent after-hours Wednesday after it entered into a Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co., as sales agent, under which the Company may, from time to time, sell shares of its …
StreetInsider · 3/27/2013
Merrill Lynch has a $5 target, and the consensus target stands at $4.45. The stocks closed Thursday at $3.59. Zogenix Inc. (NASDAQ: ZGNX) is a top name to buy at Oppenheimer for 2014. The FDA recently approved its top new drug Zohydro. The drug is …
24/7 Wall ST · 12/27/2013
Both Zogenix, Inc. (NASDAQ:ZGNX) and Derma Sciences Inc (NASDAQ:DSCI) are microcaps with market capitalizations of $204.72 million and $205.87 million respectively. The most popular stock picks of hedge funds, on the other hand are all large cap …
INSIDER MONKEY · 3/19/2015
Oct 28, 2013 (ACCESSWIRE via COMTEX) -- New York, NY - (ACCESSWIRE) - 10/28/2013 - Equity Profile Report initiates its Health-care Active Stock Watch List adding Synta Pharmaceuticals Corp. SNTA, -3.86% Dendreon Corp. DNDN Zogenix, Inc.
Market Watch · 10/28/2013